CN108969611A - The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness - Google Patents

The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness Download PDF

Info

Publication number
CN108969611A
CN108969611A CN201811226524.7A CN201811226524A CN108969611A CN 108969611 A CN108969611 A CN 108969611A CN 201811226524 A CN201811226524 A CN 201811226524A CN 108969611 A CN108969611 A CN 108969611A
Authority
CN
China
Prior art keywords
ethyl alcohol
teenager
volatile oil
fructus
treated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811226524.7A
Other languages
Chinese (zh)
Inventor
黄凤娥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201811226524.7A priority Critical patent/CN108969611A/en
Publication of CN108969611A publication Critical patent/CN108969611A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness, the Chinese prescription used includes Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, semen ziziphi spinosae, Radix Polygalae, Schisandra chinensis, fushen, fructus lycii, Fructus Corni, rhizoma acori graminei, fructus viticis, moxibustion Radix Glycyrrhizae, pearl powder, cassia seed, aloe, wild chrysanthemum, borneol, the Western medicine prescription used includes lutein ester, vitamin E lotion, External-applicationtraditional traditional Chinese medicinal finished product is made in Western medicine prescription and Chinese prescription by four steps, step A: prepares volatile oil clathrate compound；Step B: filtrate preparation；Step C: dry cream preparation；Step D: by dry cream after gained volatile oil clathrate compound, crushing in step A, C, lutein ester, vitamin E lotion, lactose and ethyl alcohol is added.The effective component of the various drugs of the present invention directly acts on eye, gos deep into the skin of affected part, adjusts affected part blood circulation, boost metabolism, toxin is discharged, treats various teenager's visual problems and the elderly's eye macular degeneration from the root.

Description

The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness
Technical field
It is especially a kind of anti-for teenager's eyesight improving and senile eye illness the present invention relates to eye protective agents field The External-applicationtraditional traditional Chinese medicinal controlled.
Background technique
Teenager in the stage of ging to school is lack of standardization due to learning time length and with eye habit, and many eyes are suffering from not With the myopia of degree, amblyopia, strabismus, long sight, astigmatism etc., very big inconvenience is brought to teen-age study, work.It is existing for The visual problems such as myopia, amblyopia, strabismus, long sight, astigmatism there is no a kind of effective treatment method, it is generally the case that be using pendant The mode worn glasses restores eyesight, since glasses do not have any therapeutic effect, over time, if dysphotia person It does not keep good to be accustomed to eye, eyesight will continue to slowly be deteriorated；And daily wear glasses can be to wearer's life, study etc. Bring very big inconvenience.It is existing for visual problems such as myopia, amblyopia, strabismus, long sight, astigmatism, there is a method in which being exactly to perform the operation Treatment, although operative treatment effect is preferable, there is unpredictable risk in operation, will be to by patient once generation operation is unexpected Serious consequence, and long-term influence of the operative treatment on eyes are brought, present medical field is also without final conclusion, therefore, even if operation Success eyesight restored, but long-term postoperative on eye eyesight either with or without influence, even for eyes itself either with or without shadow It rings, all in unpredictable state, this is also that many dysphotia persons (including medical worker) are unwilling using operative treatment The reason of.
Senile eye illness, such as senile macular degeneration sexually revise, mainly for the aging of the elderly's eye macula lutea plot structure Retinal pigment epithelium is shown as to the phagocytosis digestion power decline of acromere disk film, as a result makes not digested completely Disk film residual body retention is deposited on Bruch film (glass-film) in basal part cell magma, and to extracellular discharge, is formed Glass-film wart, senile macular degeneration mostly occur in 45 years old or more, and it is current old age that illness rate, which increases with the age and increased, The important diseases of people's blinding.Senile macular degeneration there is no special effective treatment method, general endo-medicine treatment at present Ineffective, basic is also to use various operative treatments, and operative treatment is because have unpredictalbe consequence, and therapeutic effect is not It is good, therefore there is also limitations in practical application.
The actually either various visual problems of teenager or senile macular degeneration eye disease, main contributor is also Be physical reason cause ocular circulation it is unsmooth, it is metabolic slow down, toxin buildup, and then lead to reduced vision, or old People suffers from macular degeneration eye illness.
Summary of the invention
After overcoming the problems, such as that myopia, amblyopia, strabismus, long sight, astigmatism occurs in existing teenager, wears glasses and brought to people Inconvenience, glasses cannot play therapeutic effect, and using operative treatment, there are various disadvantages and hidden danger and the elderly to suffer from macula lutea After being denaturalized eye disease, because without effective treatment method, surgical result is bad, and it is increasingly severe to will lead to macular degeneration Various drawbacks have the Chinese medicine proportion of good therapeutic effect to associate with the present invention provides a kind of using a variety of pairs of eye diseases, in conjunction with Liniment is made in lutein ester, vitamin E lotion jointly, or is applied directly to circumference of eyes skin, easy to use, various medicines The effective component of object directly acts on each acupuncture point of eye, gos deep into the skin of affected part, adjusts affected part blood circulation, promotes new old generation It thanks, toxin is discharged, treat various teenager's visual problems and the elderly's eye macular degeneration from the root, thus reach eyesight and mention Liter and the External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness without any side effects.
The technical solution adopted by the present invention to solve the technical problems is:
The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness, it is characterised in that including Chinese medicine Prescription and Western medicine prescription, the Chinese prescription used include Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, semen ziziphi spinosae, Radix Polygalae, Schisandra chinensis, fushen, Fructus lycii, Fructus Corni, rhizoma acori graminei, fructus viticis, moxibustion Radix Glycyrrhizae, pearl powder, cassia seed, aloe, wild chrysanthemum, borneol, the Western medicine used Prescription includes lutein ester, vitamin E lotion, and externally applied Chinese medicine combination is made in Western medicine prescription and Chinese prescription by four steps Step A: object finished product prepares volatile oil clathrate compound；Step B: filtrate preparation；Step C: dry cream preparation；Step D: will be in step A, C Dry cream after gained volatile oil clathrate compound, crushing, after addition lutein ester, vitamin E lotion, lactose and ethyl alcohol are uniformly mixed Obtain External-applicationtraditional traditional Chinese medicinal finished product.
In the Chinese prescription, various drug deals are as follows: Radix Codonopsis 60-100g, Rhizoma Atractylodis Macrocephalae 30-50g, Rhizoma Chuanxiong 30-50g, when Return 50-80g, semen ziziphi spinosae 60-100g, Radix Polygalae 30-50g, Schisandra chinensis 30-60g, fushen 30-50g, fructus lycii 30-80g, Fructus Corni 20-50g, rhizoma acori graminei 20-40g, fructus viticis 30-50g, moxibustion Radix Glycyrrhizae 10-30g, pearl powder 30-50g, cassia seed 30-50g, aloe 60-100g, wild chrysanthemum 50-80g, borneol 20-30g.
In the Western medicine prescription, various drug components are as follows: 3-16 grams of lutein ester, 0.2-0.4 grams of vitamin E lotion.
The step A prepare in volatile oil clathrate compound process, with cassia seed, aloe, wild chrysanthemum, Fructus Corni, stone Chang Pu, 6-10 times of weight of fructus viticis total amount water, utilize extraction by steam distillation cassia seed, aloe, wild chrysanthemum, Fructus Corni, stone Volatile oil in calamus, fructus viticis is prepared into volatile oil clathrate compound in conjunction with β-CD (cyclodextrine) after volatile oil extracting is collected, The ratio of volatile oil and β-CD are 1: 4-9, in preparation, will volatilize oil and are stirred at a temperature of 30-70 DEG C using mixing plant with β-CD It mixes 30-90 minutes, then filters, then with drying equipment at a temperature of 30-60 DEG C, after will volatilize oil and the drying of β-CD mixture Volatile oil clathrate compound finished product can be obtained, the aqueous solution after distillation is separately collected with utensil spare.
The step B is carried out in filtrate preparation section, by cassia seed, aloe, wild chrysanthemum, Fructus Corni, stone Chang in step A Pu, fructus viticis the dregs of a decoction, with Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, semen ziziphi spinosae, Radix Polygalae, Schisandra chinensis, fushen, fructus lycii, borneol, treasure Pearl powder, moxibustion Radix Glycyrrhizae add water to cook 2-4 times, 1-3 hours each, first and second time with 16-20 times of water, third and fourth time is with 12-18 times Water, after then repeatedly decocting medical fluid merge filtering after, then in step A distill rear solution merge, obtain filtrate.
The step C is carried out in dry cream preparation section, and filtrate obtained by step B is concentrated using concentration method, is mixed after concentration The ethyl alcohol that 60%-70% (V/V) is added in object is handled using alcohol precipitation process method, then places solidliquid mixture after alcohol precipitation 18-26 hours, supernatant is taken within 18-26 hours to recycle ethyl alcohol, solidliquid mixture after recycling ethyl alcohol is dense with Process is concentrated under reduced pressure Contracting obtains dry cream, and dry cream is ground into pulverizer to 80 mesh are spare, and ethyl alcohol uses the medical rank ethyl alcohol of 60%-70% (V/V), The dosage of ethyl alcohol guarantees that filtrate sufficiently dilutes.
The step D carries out the dry cream after gained volatile oil clathrate compound, crushing in step A, C lutein ester, dimension is added Raw element E lotion, lactose and ethyl alcohol obtain in External-applicationtraditional traditional Chinese medicinal finished product process after being uniformly mixed, and ethyl alcohol uses 75%- The medical rank ethyl alcohol of 95% (V/V), the dosage of ethyl alcohol guarantee that emulsus is presented just in External-applicationtraditional traditional Chinese medicinal finished product after mixing Can, lactose can also be replaced using sucrose.
The medicine have the advantages that the present invention use a variety of pairs of eye diseases have good therapeutic effect Chinese medicine proportion for 5, in conjunction with lutein ester, vitamin E lotion, through the advanced steam distillation in existing pharmaceutical field, concentration method, alcohol precipitation work Finished product made from skill etc., when use, are applied directly to circumference of eyes skin, may also be fabricated which that application is attached to circumference of eyes, using more Convenient, the present invention has effects that nourish the liver to improve visual acuity, disinfects and move back screen, expelling wind and clearing away heat removing toxic substances, nourishing qi and blood, nourishing kidney-YIN, Yi Jifu Just do not staying it is evil, get rid of evils do not hurt just, prevention nebula remained the effect of；The effective component of various drugs directly acts on each cave of eye Position is goed deep into the skin of affected part, adjusts affected part blood circulation, boost metabolism, toxin is discharged, and treats from the root various green few Thus year visual problems and the elderly's eye macular degeneration etc. have achieved the effect that eyesight promotion and without any side effects.This Invention overcomes after myopia, amblyopia, strabismus, long sight, astigmatism problem occurs in existing teenager, wears glasses to people's bring not Just, glasses cannot play therapeutic effect, and using operative treatment, there are various disadvantages and hidden danger and the elderly to suffer from macular degeneration After eye disease, because without effective treatment method, surgical result is bad, it will lead to increasingly severe various of macular degeneration Drawback.Prescription of the present invention is rigorous, easy to use, and effect is good, therefore the application prospect having had.
Detailed description of the invention
Fig. 1 is preparation process block diagram signal of the present invention.
Specific embodiment
Shown in Fig. 1, for the External-applicationtraditional traditional Chinese medicinal that teenager's eyesight improving and senile eye illness are prevented and treated, feature exists In including Chinese prescription and Western medicine prescription, the Chinese prescription used includes Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, semen ziziphi spinosae, Radix Polygalae, five Taste, fushen, fructus lycii, Fructus Corni, rhizoma acori graminei, fructus viticis, moxibustion Radix Glycyrrhizae, pearl powder, cassia seed, aloe, wild chrysanthemum, borneol, The Western medicine prescription used includes lutein ester, vitamin E lotion, and Western medicine prescription and Chinese prescription are made outer by four steps Chinese medicine composition finished product is applied, step A: prepares volatile oil clathrate compound；Step B: filtrate preparation；Step C: dry cream preparation；Step D: By dry cream after gained volatile oil clathrate compound, crushing in step A, C, lutein ester, vitamin E lotion, lactose and ethyl alcohol is added and stirs It mixes and obtains External-applicationtraditional traditional Chinese medicinal finished product after mixing.
In embodiment 1, in Chinese prescription, various drug components are as follows: Radix Codonopsis 80g, Rhizoma Atractylodis Macrocephalae 45g, Rhizoma Chuanxiong 38g, Radix Angelicae Sinensis 65g, semen ziziphi spinosae 90g, Radix Polygalae 42g, Schisandra chinensis 50g, fushen 40g, fructus lycii 75g, Fructus Corni 40g, rhizoma acori graminei 30g, fructus viticis 40g, moxibustion Radix Glycyrrhizae 25g, pearl powder 40g, cassia seed 35g, aloe 90g, wild chrysanthemum 70g, borneol 25g.In Western medicine prescription, various medicines Object component is as follows: 10 grams of lutein ester, 0.3 gram of vitamin E lotion.
In embodiment 2, in Chinese prescription, various drug components are as follows: Radix Codonopsis 75g, Rhizoma Atractylodis Macrocephalae 50g, Rhizoma Chuanxiong 40g, Radix Angelicae Sinensis 55g, semen ziziphi spinosae 85g, Radix Polygalae 40g, Schisandra chinensis 45g, fushen 35g, fructus lycii 80g, Fructus Corni 30g, rhizoma acori graminei 20g, fructus viticis 35g, moxibustion Radix Glycyrrhizae 20g, pearl powder 40g, cassia seed 30g, aloe 80g, wild chrysanthemum 60g, borneol 20g.In Western medicine prescription, various medicines Object component is as follows: 8 grams of lutein ester, 0.4 gram of vitamin E lotion.
Shown in Fig. 1, step A prepare in volatile oil clathrate compound process, with cassia seed, aloe, wild chrysanthemum, mountain Zhu Cornel, rhizoma acori graminei, 8 times of weight of fructus viticis total amount water, utilize extraction by steam distillation cassia seed, aloe, wild chrysanthemum, mountain Zhu Cornel, rhizoma acori graminei, the volatile oil in fructus viticis are prepared into volatile oil packet in conjunction with β-CD (cyclodextrine) after volatile oil extracting is collected The ratio of conjunction object, volatile oil and β-CD are 1: 7, in preparation, will volatilize oil and are stirred at a temperature of 60 DEG C using mixing plant with β-CD It mixes 70 minutes, then filters, then with drying equipment at a temperature of 55 DEG C, can be obtained after will volatilize oil and the drying of β-CD mixture To volatile oil clathrate compound finished product, the aqueous solution after distillation is separately collected with utensil spare.Step B is carried out in filtrate preparation section, will The dregs of a decoction of cassia seed, aloe, wild chrysanthemum, Fructus Corni, rhizoma acori graminei, fructus viticis in step A, with Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, acid Jujube kernel, Radix Polygalae, Schisandra chinensis, fushen, fructus lycii, borneol, pearl powder, moxibustion Radix Glycyrrhizae add water to cook 4 times, and 2 hours every time, first and second Secondary 20 times of water, third and fourth time use 12 times of water, after then repeatedly decocting medical fluid merge filtering after, then in step A distillation after Aqueous solution merges, and obtains filtrate.Step C is carried out in dry cream preparation section, and filtrate obtained by step B is concentrated using concentration method, dense The ethyl alcohol that 60%-70% (V/V) is added after contracting in mixture is handled using alcohol precipitation process method, then mixes solid-liquid after alcohol precipitation Closing after object is placed 24 hours, 24 hours takes supernatant to recycle ethyl alcohol, solidliquid mixture after recycling ethyl alcohol is used, technique is concentrated under reduced pressure Method is concentrated to get dry cream, and dry cream is ground into pulverizer to 80 mesh are spare, and ethyl alcohol uses the medical rank of 60%-70% (V/V) Ethyl alcohol, the dosage of ethyl alcohol guarantee that filtrate sufficiently dilutes.Step D, carrying out will be after gained volatile oil clathrate compound, crushing in step A, C Dry cream is added after lutein ester, vitamin E lotion, lactose and ethyl alcohol are uniformly mixed and obtains External-applicationtraditional traditional Chinese medicinal finished product In process, ethyl alcohol uses the medical rank ethyl alcohol of 75%-95% (V/V), and the dosage of ethyl alcohol guarantees External-applicationtraditional traditional Chinese medicinal finished product After mixing present emulsus can, lactose can also using sucrose replace (lactose and dosage of sucrose 20g or so).
In side of the present invention, Radix Codonopsis is sweet in flavor, mild-natured, returns spleen, lung channel, the function with tonifying middle-Jiao and Qi, nourishes blood and promotes the production of body fluid, decompression etc. Effect.Rhizoma Atractylodis Macrocephalae bitter, sweet, warm-natured, returns spleen, stomach meridian have effects that strengthening the spleen and replenishing qi etc..Rhizoma Chuanxiong is sweet in flavor, pungent, warm-natured, return liver, gallbladder, Pericardium channel has wind-dispelling, promoting blood circulation, moisturizing and other effects, is conducive to ocular nerve nutrition improvement.Radix Angelicae Sinensis is sweet in flavor, pungent, warm-natured, returns liver Through, the heart channel of Hang-Shaoyin, the spleen channel, there is replenishing and activating blood, increase immunity and other effects, can be used for stagnation of QI and blood, protect liver myogenic etc..Semen ziziphi spinosae taste It is sweet, sour, mild-natured, return liver, gallbladder, the heart channel of Hang-Shaoyin, there is nourishing heart tonifying liver, antitoxic heart-soothing and sedative, promote the production of body fluid and other effects.It is Radix Polygalae bitter, pungent, warm-natured, return The heart channel of Hang-Shaoyin, kidney channel, lung channel, have effects that eliminating the phlegm have one's ideas straightened out, dissipation carbuncle swells etc..Schisandra chinensis is sour, sweet, warm-natured, return lung, the heart, kidney channel, With astringency inducing, nourishing generate fluid, kidney calming and other effects.Fushen is sweet in flavor, light, mild-natured, return heart, the spleen channel, has calming heart, calms the nerves And other effects.Fructus lycii is sweet in flavor, mild-natured, returns liver and kidney channel, have nourshing kidney, moistening lung, tonifying liver, improving eyesight and other effects, for liver-kidney Yin deficiency, Soreness and weakness of waist and knees, dizziness, dizzy, the more tears of blurred vision etc..Fructus Corni is sour, puckery, slightly warm in nature, returns liver and kidney channel, has and tonifies the liver and kidney, receives Puckery prevent prolapse and other effects.Rhizoma acori graminei acrid flavour, hardship, slightly warm in nature, return heart, liver, the spleen channel have dampness elimination appetizing, slit phlegm of having one's ideas straightened out, inducing resuscitation intelligence development And other effects.Fructus viticis acrid flavour, hardship, cold nature, return lung, bladder, Liver Channel have dispelling wind and heat from the body, head clearing and other effects, can be used for The mesh that swoons is dark, pain etc. in red eyes with many tear, mesh eyeball.Moxibustion Radix Glycyrrhizae is sweet in flavor, mild-natured, return heart, spleen, lung, stomach meridian, has tonifying spleen stomach function regulating, benefit Gas answers arteries and veins and other effects.Cassia seed is sweet in flavor, bitter, cold nature, returns large intestine channel, has and clears liver and improve vision and other effects.Pearl taste is salty, cold in nature, Return liver, the heart channel of Hang-Shaoyin, have it is calming the liver, clear liver and improve vision and other effects.Aloe bitter, cold in nature, return lung, large intestine channel have the function such as heat-clearing Effect.Wild chrysanthemum bitter, pungent, cold nature, return lung, Liver Channel have clearing heat and detoxicating, removing nebula for improving eyesight and other effects.The importance of lutein Nutrition educational circles in the whole world is all affirmed why the macula area of human eye is yellow color, exactly because it is filled with leaf Huang Element and its homologous series object, lutein filter blue light and oxidation resistant effect, are to aid in the critical nutrients element of eye development, because This, lutein is also compared to " stealthy sunglasses " by someone；One important biological function of lutein is exactly to protect view Film prevents the damage of the blue light close with ultraviolet wavelength, thus, it is possible to protect the eyesight of people, while to eye Age related macular Denaturation has prevention effect.Vitamin E (Vitamin E) is a kind of liposoluble vitamin, and it is most main that hydrolysate, which is tocopherol, One of antioxidant wanted, recent medical research show that discovery vitamin E can inhibit the lipid peroxidation reaction in ocular lens body, Make peripheral vasodilation, improves blood circulation, pre- Anti-myopic eye occurrence and development, while can also play to eye Age related macular Certain preventive and therapeutic effect.Above-mentioned Chinese medicine all has good therapeutic effect to eye, through the advanced vapor in existing pharmaceutical field Finished product made from the way of distillation, concentration method, alcohol precipitation process etc., when use, are applied directly to circumference of eyes skin, may also be fabricated which application It is attached to circumference of eyes, it is more convenient to use, have and nourishes the liver to improve visual acuity, disinfect that it is feeding to move back screen, expelling wind and clearing away heat removing toxic substances, nourishing qi and blood, nourshing kidney Effect and righting of yin do not stay it is evil, get rid of evils do not hurt just, prevention nebula remained the effect of, the effective component of various drugs is direct Each acupuncture point of eye is acted on, gos deep into the skin of affected part, adjusts affected part blood circulation, boost metabolism, toxin is discharged, from root It is upper to treat various teenager's visual problems and the elderly's eye macular degeneration, thus reach eyesight promotion and without any poison pair The effect of effect.After there is the problems such as myopia, amblyopia, strabismus, long sight, astigmatism the present invention overcomes existing teenager, match hyperphoria with fixed eyeballs Mirror is inconvenient to people's bring, and glasses cannot play therapeutic effect, and using operative treatment, there are various disadvantages and hidden danger, and old age After people suffers from macular degeneration eye disease, because without effective treatment method, surgical result is bad, it will lead to macular degeneration and get over Carry out more serious various drawbacks.Prescription of the present invention is rigorous, easy to use, and effect is good, therefore the application prospect having had.
The present invention carries out medication effect verifyings to 100 case personnel, be divided into adolescent myopia, amblyopia, strabismus, long sight, Astigmatism therapeutic effect validation group, between this group verifying 16 years old to 30 years old age of case personnel, men and women each 25,50 personnel are used The present invention continuous 90 days ophthalmic administrations treatment, is administered once a day, before treatment and after treatment respectively to the eyesight of verifying example one by one It is counted.In addition men and women each 25 old macular degeneration in humans eye disease control efficiency is verified, this group verifying case Between 45 years old to the 70 years old age of personnel, 50, using the continuous 90 days ophthalmic administrations treatment of the present invention, are administered once a day, before verifying And the eyesight and macular degeneration situation of verifying example are counted one by one respectively after verifying.By 90 days continuous uses, teenager Myopia, amblyopia, strabismus, long sight, in astigmatism therapeutic effect validation group, obvious effective rate reaches 90 percent, and effective person's eyesight has Improve；In old macular degeneration in humans eye disease control efficiency validation group, obvious effective rate reaches 85 percent, effective person's eyesight There is improvement, and eye macular degeneration has obtained good change in various degree.The above results sufficiently demonstrate curative effect of the invention.
Basic principles and main features and advantages of the present invention of the invention have been shown and described above, for this field skill For art personnel, it is clear that the present invention is limited to the details of above-mentioned exemplary embodiment, and without departing substantially from spirit or base of the invention In the case where eigen, the present invention can be realized in other specific forms.It therefore, in all respects, should all be by reality Apply example and regard exemplary as, and be non-limiting, the scope of the present invention by appended claims rather than above description It limits, it is intended that including all changes that fall within the meaning and scope of the equivalent elements of the claims in the present invention. Any reference signs in the claims should not be construed as limiting the involved claims.
In addition, it should be understood that although this specification is described in terms of embodiments, but not each embodiment is only wrapped Containing an independent technical solution, this description of the specification is merely for the sake of clarity, and those skilled in the art should It considers the specification as a whole, the technical solutions in the various embodiments may also be suitably combined, forms those skilled in the art The other embodiments being understood that.

Claims (7)

1. the External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness, it is characterised in that including Chinese medicine group Side and Western medicine prescription, the Chinese prescription used includes Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, semen ziziphi spinosae, Radix Polygalae, Schisandra chinensis, fushen, Chinese holly Matrimony vine, Fructus Corni, rhizoma acori graminei, fructus viticis, moxibustion Radix Glycyrrhizae, pearl powder, cassia seed, aloe, wild chrysanthemum, borneol, the Western medicine group used Side includes lutein ester, vitamin E lotion, and External-applicationtraditional traditional Chinese medicinal is made in Western medicine prescription and Chinese prescription by four steps Step A: finished product prepares volatile oil clathrate compound；Step B: filtrate preparation；Step C: dry cream preparation；Step D: by institute in step A, C Volatile oil clathrate compound, dry cream after crushing, be added after lutein ester, vitamin E lotion, lactose and ethyl alcohol are uniformly mixed i.e. Obtain External-applicationtraditional traditional Chinese medicinal finished product.
2. the externally applied Chinese medicine combination according to claim 1 prevented and treated for teenager's eyesight improving and senile eye illness Object, it is characterised in that in Chinese prescription, various drug deals are as follows: Radix Codonopsis 60-100g, Rhizoma Atractylodis Macrocephalae 30-50g, Rhizoma Chuanxiong 30-50g, when Return 50-80g, semen ziziphi spinosae 60-100g, Radix Polygalae 30-50g, Schisandra chinensis 30-60g, fushen 30-50g, fructus lycii 30-80g, Fructus Corni 20-50g, rhizoma acori graminei 20-40g, fructus viticis 30-50g, moxibustion Radix Glycyrrhizae 10-30g, pearl powder 30-50g, cassia seed 30-50g, aloe 60-100g, wild chrysanthemum 50-80g, borneol 20-30g.
3. the externally applied Chinese medicine combination according to claim 1 prevented and treated for teenager's eyesight improving and senile eye illness Object, it is characterised in that in Western medicine prescription, various drug components are as follows: 3-16 grams of lutein ester, 0.2-0.4 grams of vitamin E lotion.
4. the externally applied Chinese medicine combination according to claim 1 prevented and treated for teenager's eyesight improving and senile eye illness Object, it is characterised in that step A prepare in volatile oil clathrate compound process, with cassia seed, aloe, wild chrysanthemum, Fructus Corni, stone Calamus, 6-10 times of weight of fructus viticis total amount water, using extraction by steam distillation cassia seed, aloe, wild chrysanthemum, Fructus Corni, Volatile oil in rhizoma acori graminei, fructus viticis after volatile oil extracting is collected, is prepared into volatile oil clathrate compound in conjunction with β-CD, volatile oil with The ratio of β-CD is 1: 4-9, in preparation, will volatilize oil and is divided at a temperature of 30-70 DEG C using mixing plant stirring 30-90 with β-CD Then clock filters, then with drying equipment at a temperature of 30-60 DEG C, can be obtained after will volatilize oil and the drying of β-CD mixture Volatile oil clathrate compound finished product, the aqueous solution after distillation are separately collected with utensil spare.
5. the externally applied Chinese medicine combination according to claim 4 prevented and treated for teenager's eyesight improving and senile eye illness Object, it is characterised in that step B is carried out in filtrate preparation section, by cassia seed, aloe, wild chrysanthemum, Fructus Corni, stone Chang in step A Pu, fructus viticis the dregs of a decoction, with Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, semen ziziphi spinosae, Radix Polygalae, Schisandra chinensis, fushen, fructus lycii, borneol, treasure Pearl powder, moxibustion Radix Glycyrrhizae add water to cook 2-4 times, 1-3 hours each, first and second time with 16-20 times of water, third and fourth time is with 12-18 times Water, after then repeatedly decocting medical fluid merge filtering after, then in step A distill rear solution merge, obtain filtrate.
6. the externally applied Chinese medicine combination according to claim 5 prevented and treated for teenager's eyesight improving and senile eye illness Object, it is characterised in that step C is carried out in dry cream preparation section, and filtrate obtained by step B is concentrated using concentration method, is mixed after concentration The ethyl alcohol for closing addition 60%-70% in object is handled using alcohol precipitation process method, and solidliquid mixture after alcohol precipitation is then placed 18- 26 hours, supernatant is taken within 18-26 hours to recycle ethyl alcohol, solidliquid mixture after recycling ethyl alcohol is concentrated to give with reduced pressure Process To dry cream, dry cream is ground into pulverizer to 80 mesh are spare, ethyl alcohol uses the medical rank ethyl alcohol of 60%-70%, the use of ethyl alcohol Amount guarantees that filtrate sufficiently dilutes.
7. the externally applied Chinese medicine combination according to claim 6 prevented and treated for teenager's eyesight improving and senile eye illness Object, it is characterised in that step D carries out the dry cream after gained volatile oil clathrate compound, crushing in step A, C lutein ester, dimension is added Raw element E lotion, lactose and ethyl alcohol obtain in External-applicationtraditional traditional Chinese medicinal finished product process after being uniformly mixed, and ethyl alcohol uses 75%- 95% medical rank ethyl alcohol, the dosage of ethyl alcohol guarantee External-applicationtraditional traditional Chinese medicinal finished product present after mixing emulsus can, cream Sugar can also be replaced using sucrose.
CN201811226524.7A 2018-10-22 2018-10-22 The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness Pending CN108969611A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811226524.7A CN108969611A (en) 2018-10-22 2018-10-22 The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811226524.7A CN108969611A (en) 2018-10-22 2018-10-22 The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness

Publications (1)

Publication Number Publication Date
CN108969611A true CN108969611A (en) 2018-12-11

Family

ID=64544526

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811226524.7A Pending CN108969611A (en) 2018-10-22 2018-10-22 The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness

Country Status (1)

Country Link
CN (1) CN108969611A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1085792A (en) * 1993-07-30 1994-04-27 高峰 Treat bathomorphic liniment and preparation method thereof
CN1745830A (en) * 2005-09-29 2006-03-15 李广中 Preparation of Zijing paste for eye vision recovery
CN102008596A (en) * 2010-12-01 2011-04-13 贾晓萍 Chinese medicine eye compressing bag for treating myopic eye and using method thereof
CN104740644A (en) * 2013-07-03 2015-07-01 郑州市新视明科技工程有限公司 Preparation method of composition for promoting skin compliance and ingredient absorption of eye hydropathic compress agent
CN107875289A (en) * 2017-06-21 2018-04-06 苏州雅致堂草本科技有限公司 A kind of preparation method of the pure Chinese medicine hydrogel eyeshield pad pasting of protection eyesight
CN108175806A (en) * 2018-01-23 2018-06-19 贵州康琦药械有限公司 A kind of Chinese medicine eye paste and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1085792A (en) * 1993-07-30 1994-04-27 高峰 Treat bathomorphic liniment and preparation method thereof
CN1745830A (en) * 2005-09-29 2006-03-15 李广中 Preparation of Zijing paste for eye vision recovery
CN102008596A (en) * 2010-12-01 2011-04-13 贾晓萍 Chinese medicine eye compressing bag for treating myopic eye and using method thereof
CN104740644A (en) * 2013-07-03 2015-07-01 郑州市新视明科技工程有限公司 Preparation method of composition for promoting skin compliance and ingredient absorption of eye hydropathic compress agent
CN107875289A (en) * 2017-06-21 2018-04-06 苏州雅致堂草本科技有限公司 A kind of preparation method of the pure Chinese medicine hydrogel eyeshield pad pasting of protection eyesight
CN108175806A (en) * 2018-01-23 2018-06-19 贵州康琦药械有限公司 A kind of Chinese medicine eye paste and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
徐建玲: "综合治疗中小学生近视的疗效观察 ", 《内蒙古中医药》 *
林颖等: "中医辨证治疗老年性黄斑变性的视觉生理变化意义", 《福建中医学院学报》 *
柴兰琴等: "《食品分析与食品安全》", 31 August 2010, 西南交通大学出版社 *
钟润先: "预防为主 防治结合 深入开展"防近"科学研究――各地21篇论文综合报道及十六种方法、十九种药物"防近"疗效的述评 ", 《中国学校卫生》 *

Similar Documents

Publication Publication Date Title
CN104225265B (en) A kind of Traditional Chinese medicine composition for relieving asthenopia
CN102188604A (en) Medicament for treating myopia and presbyopia
CN106421695A (en) Traditional Chinese medicine composition for eye care
CN109010761A (en) A kind of eye externally applied drug and preparation method thereof alleviated visual fatigue and improve eyesight
CN110354204A (en) It is a kind of to have effects that the composition of improving eyesight and its preparation, application method
CN104069364A (en) Traditional Chinese medicine for treating optic atrophy
CN106490612A (en) A kind of women help cream and preparation method
CN104971304A (en) Xerophthalmia treatment medicine
CN110327401A (en) Treat amblyopia and the Chinese medicinal plaster of myopia and preparation method thereof
CN106262850A (en) A kind of miscellaneous grain crops health instant powder and production technology
CN110448618A (en) A kind of Chinese medicine preparation and preparation method thereof for treating eyesight
CN109954125A (en) It is a kind of to treat near-sighted Chinese medicine lotion for external use and preparation method thereof
CN104474509A (en) Medicine patch for conditioning eye refraction and preparation method of medicine patch
CN108969611A (en) The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness
CN106344827A (en) Eye drops for treating presbyopia and preparation method of eye drops
CN110478442A (en) A kind of Multifunctional eye drops and preparation method thereof
CN110269895A (en) A kind of visual rehabilitation Chinese medicine composition containing fresh Chinese medicine and preparation method thereof, preparation
CN108498615A (en) A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle
CN113925910B (en) A topical Chinese medicinal composition for treating myopia, and its preparation method
CN111450179A (en) Eyesight improving and eye protecting composition and application and preparation method thereof
CN109432191A (en) A kind of eye sticker and preparation method thereof for alleviating asthenopia
CN108743846A (en) A kind of improving eyesight cream, improving eyesight water, improving eyesight drink and preparation method thereof
CN112274558B (en) Pharmaceutical composition for treating under-eye puffiness and dark circles and preparation method and application thereof
CN115444903A (en) Application of rehabilitation eyesight oral liquid in preparation of eyesight improving medicine
CN113893087B (en) Chinese medicine eye-mask for regulating myopia, amblyopia, astigmatism and asthenopia and its making method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181211